Financials

Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4568
TXMD
TherapeuticsMD, Inc. - Common Stock
1.97 USD0.00%-0.51%-13.97%+71.30%22.80 M USD
4576
RMTI
Rockwell Medical, Inc. - Common Stock
5.63 USD-0.71%-4.74%+753.03%+416.51%22.22 M USD
4730
BFRI
Biofrontera Inc. - Common Stock
1.06 USD-4.50%-8.62%+7.07%+27.71%13.57 M USD
4896
YCBD
cbdMD, Inc. Common Stock
0.67 USD0.00%-5.63%0.00%-5.63%7.03 M USD

Frequently asked questions about Akanda Corp. - Common Shares

What is the Akanda Corp. - Common Shares stock price today?

The current price of Akanda Corp. - Common Shares (AKAN) is 9.48. Over the past 24 hours, the stock has changed by -1.04%. Follow the AKAN chart for real-time price dynamics.

What is the stock ticker of Akanda Corp. - Common Shares?

Akanda Corp. - Common Shares trades under the ticker AKAN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Akanda Corp. - Common Shares stock going up?

AKAN has changed by -16.99% over the last week, -46.29% over the last month, and +629.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Akanda Corp. - Common Shares have?

As of the latest available data, Akanda Corp. - Common Shares has 6 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Akanda Corp. - Common Shares stock?

You can buy Akanda Corp. - Common Shares (AKAN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Akanda Corp. - Common Shares stock?

Investing in Akanda Corp. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AKAN chart and related analysis on metatrader.com as part of your research.

News